Hormone therapy update
A decade ago, women used hormone therapy (HT) not only to relieve menopause symptoms, but also to prevent chronic conditions such as heart disease, osteoporosis, and dementia. That was before results of the landmark Women's Health Initiative (WHI) study were released in 2002, revealing that taking estrogen and progestin after menopause may increase women's risk for stroke, heart disease, blood clots, and breast cancer. Today, only about 5% of postmenopausal women are still on these hormones, and their reasons for taking them have changed.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
